{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:22:42Z","timestamp":1790468562402,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract <\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polyunsaturated fatty acid (PUFA) supplementation has been reported to improve disease activity in inflammatory rheumatic diseases (IRDs). However, data are often conflicting and studies insufficiently large to draw conclusions. This systematic literature review and meta-analysis aimed to better estimate the effect of oral supplementation with omega (n)-3 and n-6 PUFA on IRD activity in terms of duration, dose, type, and source.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The literature was searched in PubMed, EMBASE, and Cochrane Library databases up to October 2020. Studies were reviewed in accordance with PRISMA guidelines. The effect of PUFA supplementation on disease activity was expressed as the standardized mean difference (95% CI). Metaregression and subgroup analyses involved type of IRD, Jadad score, PUFA source (animal or vegetable), and doses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We obtained 42 references; 30 randomized controlled studies were included comparing the effects of PUFA versus control on disease activity (710 IRD patients receiving PUFA supplementation and 710 controls, most with rheumatoid arthritis). We found a significant improvement in pain, swollen and tender joint count, Disease Activity Score in 28 joints, and Health Assessment Questionnaire score in IRD patients receiving PUFA supplementation as compared with controls, with a significant decrease in erythrocyte sedimentation rate but not C-reactive protein level. Although meta-regression revealed no difference by IRD type or source or dose of PUFA supplementation, subgroup analysis revealed more parameters significantly improved with animal- than vegetable-derived PUFAs and 3- to 6-month supplementation. Most studies examined high-dose supplementation (&gt;2 g\/day).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>PUFA consumption, especially omega-3 from animal source &gt;2 g\/day, may improve IRD activity and might be an adjuvant therapy in rheumatoid arthritis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The protocol was registered at PROSPERO (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=253685\">CRD42021253685<\/jats:ext-link>).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-022-02781-2","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T09:08:26Z","timestamp":1651914506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6371-740X","authenticated-orcid":false,"given":"Johanna","family":"Sigaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Guillaume","family":"Letarouilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Soubrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Czernichow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9-Marc","family":"Flipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Sellam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Da\u00efen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"key":"2781_CR1","doi-asserted-by":"crossref","unstructured":"Cassotta M, Forbes-Hernandez TY, Cianciosi D, Elexpuru Zabaleta M, Sumalla Cano S, Dominguez I, et al. Nutrition and Rheumatoid Arthritis in the 'Omics' Era. Nutrients. 2021;13(3):763","DOI":"10.3390\/nu13030763"},{"key":"2781_CR2","unstructured":"Vitamin D and marine n-3 fatty acid supplementation and prevention of autoimmune disease in the VITAL randomized controlled trial [Internet]. ACR Meeting Abstracts. [cit\u00e9 2 janv 2022]. Disponible sur: https:\/\/acrabstracts.org\/abstract\/vitamin-d-and-marine-n-3-fatty-acid-supplementation-and-prevention-of-autoimmune-disease-in-the-vital-randomized-controlled-trial\/"},{"issue":"1","key":"2781_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/art.41487","volume":"73","author":"Y Nguyen","year":"2021","unstructured":"Nguyen Y, Salliot C, Gelot A, Gambaretti J, Mariette X, Boutron-Ruault M-C, et al. Mediterranean diet and risk of rheumatoid arthritis: findings from the French E3N-EPIC cohort study. Arthritis Rheumatol. 2021;73(1):69\u201377.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"2781_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrrheum.2017.216","volume":"14","author":"JA Sparks","year":"2018","unstructured":"Sparks JA, Costenbader KH. Rheumatoid arthritis in 2017: protective dietary and hormonal factors brought to light. Nat Rev Rheumatol. 2018;14(2):71\u20132.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"2781_CR5","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1096\/fj.201802445R","volume":"33","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck M, Hansson GK. Omega-3 fatty acids, cardiovascular risk, and the resolution of inflammation. FASEB J. 2019;33(2):1536\u20139.","journal-title":"FASEB J"},{"key":"2781_CR6","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez S, Svahn SL, Johansson ME. Effects of omega-3 fatty acids on immune cells. Int J Mol Sci. 2019;20(20):5028.","DOI":"10.3390\/ijms20205028"},{"issue":"11","key":"2781_CR7","doi-asserted-by":"publisher","first-page":"E3504","DOI":"10.3390\/nu12113504","volume":"12","author":"E Dourado","year":"2020","unstructured":"Dourado E, Ferro M, Sousa Guerreiro C, Fonseca JE. Diet as a modulator of intestinal microbiota in rheumatoid arthritis. Nutrients. 2020;12(11):E3504.","journal-title":"Nutrients"},{"issue":"2","key":"2781_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.plipres.2007.12.004","volume":"47","author":"G Schmitz","year":"2008","unstructured":"Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res. 2008;47(2):147\u201355.","journal-title":"Prog Lipid Res"},{"issue":"8","key":"2781_CR9","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/jn\/127.8.1435","volume":"127","author":"MM Johnson","year":"1997","unstructured":"Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN, et al. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr. 1997;127(8):1435\u201344.","journal-title":"J Nutr"},{"issue":"1","key":"2781_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/10446670410001670445","volume":"11","author":"VA Ziboh","year":"2004","unstructured":"Ziboh VA, Naguwa S, Vang K, Wineinger J, Morrissey BM, Watnik M, et al. Suppression of leukotriene B4 generation by ex-vivo neutrophils isolated from asthma patients on dietary supplementation with gammalinolenic acid-containing borage oil: possible implication in asthma. Clin Dev Immunol. 2004;11(1):13\u201321.","journal-title":"Clin Dev Immunol"},{"issue":"11","key":"2781_CR11","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/0895-4356(95)00028-3","volume":"48","author":"PR Fortin","year":"1995","unstructured":"Fortin PR, Lew RA, Liang MH, Wright EA, Beckett LA, Chalmers TC, et al. Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. J Clin Epidemiol. 1995;48(11):1379\u201390.","journal-title":"J Clin Epidemiol"},{"issue":"1-2","key":"2781_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.pain.2007.01.020","volume":"129","author":"RJ Goldberg","year":"2007","unstructured":"Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain. 2007;129(1-2):210\u201323.","journal-title":"Pain"},{"issue":"5","key":"2781_CR13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.arcmed.2012.06.011","volume":"43","author":"Y-H Lee","year":"2012","unstructured":"Lee Y-H, Bae S-C, Song G-G. Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Arch Med Res. 2012;43(5):356\u201362.","journal-title":"Arch Med Res"},{"key":"2781_CR14","doi-asserted-by":"crossref","unstructured":"Senftleber NK, Nielsen SM, Andersen JR, Bliddal H, Tarp S, Lauritzen L, et al. Marine oil supplements for arthritis pain: a systematic review and meta-analysis of randomized trials. Nutrients. 2017;9(1):42.","DOI":"10.3390\/nu9010042"},{"key":"2781_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.nut.2017.06.023","volume":"45","author":"A Gioxari","year":"2018","unstructured":"Gioxari A, Kaliora AC, Marantidou F, Panagiotakos DP. Intake of \u03c9-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a systematic review and meta-analysis. Nutrition. 2018;45:114\u2013124.e4.","journal-title":"Nutrition"},{"key":"2781_CR16","doi-asserted-by":"crossref","unstructured":"Daien C, Czernichow S, Letarouilly J-G, Nguyen Y, Sanchez P, Sigaux J, et al. Dietary recommendations of the French Society for Rheumatology for patients with chronic inflammatory rheumatic diseases. Joint Bone Spine. 2021;89(2):105319.","DOI":"10.1016\/j.jbspin.2021.105319"},{"issue":"7","key":"2781_CR17","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"1","key":"2781_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J. A power primer. Psychol Bull. 1992;112(1):155\u20139.","journal-title":"Psychol Bull"},{"issue":"7414","key":"2781_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"Suppl 10","key":"2781_CR20","first-page":"1050","volume":"66","author":"AC Araujo","year":"2014","unstructured":"Araujo AC, Moraes-Fontes M, Santos L, Riso N. Fatty acids and Mediterranean diet as complementary therapies for rheumatoid arthritis. Arthritis Rheum. 2014;66(Suppl 10):1050.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2781_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.nut.2004.03.023","volume":"21","author":"AA Berbert","year":"2005","unstructured":"Berbert AA, Kondo CRM, Almendra CL, Matsuo T, Dichi I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition. 2005;21(2):131\u20136.","journal-title":"Nutrition"},{"issue":"5","key":"2781_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/rheumatology\/30.5.370","volume":"30","author":"M Brzeski","year":"1991","unstructured":"Brzeski M, Madhok R, Capell HA. Evening primrose oil in patients with rheumatoid arthritis and side-effects of non-steroidal anti-inflammatory drugs. Br J Rheumatol. 1991;30(5):370\u20132.","journal-title":"Br J Rheumatol"},{"issue":"10","key":"2781_CR23","first-page":"1471","volume":"15","author":"LG Cleland","year":"1988","unstructured":"Cleland LG, French JK, Betts WH, Murphy GA, Elliott MJ. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol. 1988;15(10):1471\u20135.","journal-title":"J Rheumatol"},{"issue":"2","key":"2781_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3329\/bmrcb.v35i2.3020","volume":"35","author":"AB Das Gupta","year":"2009","unstructured":"Das Gupta AB, Hossain AKMM, Islam MH, Dey SR, Khan AL. Role of omega-3 fatty acid supplementation with indomethacin in suppression of disease activity in rheumatoid arthritis. Bangladesh Med Res Counc Bull. 2009;35(2):63\u20138.","journal-title":"Bangladesh Med Res Counc Bull"},{"issue":"10","key":"2781_CR25","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1017\/S0007114508076216","volume":"101","author":"C Dawczynski","year":"2009","unstructured":"Dawczynski C, Schubert R, Hein G, M\u00fcller A, Eidner T, Vogelsang H, et al. Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis. Br J Nutr. 2009;101(10):1517\u201326.","journal-title":"Br J Nutr"},{"key":"2781_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1476-511X-10-130","volume":"10","author":"C Dawczynski","year":"2011","unstructured":"Dawczynski C, Hackermeier U, Viehweger M, Stange R, Springer M, Jahreis G. Incorporation of n-3 PUFA and \u03b3-linolenic acid in blood lipids and red blood cell lipids together with their influence on disease activity in patients with chronic inflammatory arthritis - a randomized controlled human intervention trial. Lipids Health Dis. 2011;10:130.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"2781_CR27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.clnu.2017.02.021","volume":"37","author":"C Dawczynski","year":"2018","unstructured":"Dawczynski C, Dittrich M, Neumann T, Goetze K, Welzel A, Oelzner P, et al. Docosahexaenoic acid in the treatment of rheumatoid arthritis: a double-blind, placebo-controlled, randomized cross-over study with microalgae vs. sunflower oil. Clin Nutr. 2018;37(2):494\u2013504.","journal-title":"Clin Nutr"},{"issue":"5","key":"2781_CR28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/rheumatology\/ken024","volume":"47","author":"B Galarraga","year":"2008","unstructured":"Galarraga B, Ho M, Youssef HM, Hill A, McMahon H, Hall C, et al. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology (Oxford). 2008;47(5):665\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"2781_CR29","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/art.1780370608","volume":"37","author":"P Geusens","year":"1994","unstructured":"Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. Arthritis Rheum. 1994;37(6):824\u20139.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"2781_CR30","first-page":"448","volume":"64","author":"E Khaleghi","year":"2005","unstructured":"Khaleghi E, Heidari P, Heidari B. Efficacy of fish oil in the treatment of patients with rheumatoid arthritis. Ann Rheum Dis. 2005;64(Suppl 3):448.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2781_CR31","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.clinbiochem.2009.12.011","volume":"43","author":"S Kolahi","year":"2010","unstructured":"Kolahi S, Ghorbanihaghjo A, Alizadeh S, Rashtchizadeh N, Argani H, Khabazzi A-R, et al. Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand\/osteoprotegerin ratio in female patients with rheumatoid arthritis. Clin Biochem. 2010;43(6):576\u201380.","journal-title":"Clin Biochem"},{"issue":"6","key":"2781_CR32","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/art.1780330607","volume":"33","author":"JM Kremer","year":"1990","unstructured":"Kremer JM, Lawrence DA, Jubiz W, Digiacomo R, Rynes R, Bartholomew LE, et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis clinical and immunologic effects. Arthritis Rheum. 1990;33(6):810\u201320.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2781_CR33","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/art.1780380813","volume":"38","author":"JM Kremer","year":"1995","unstructured":"Kremer JM, Lawrence DA, Petrillo GF, Litts LL, Mullaly PM, Rynes RI, et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs clinical and immune correlates. Arthritis Rheum. 1995;38(8):1107\u201314.","journal-title":"Arthritis Rheum"},{"issue":"8422","key":"2781_CR34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0140-6736(85)92024-0","volume":"1","author":"JM Kremer","year":"1985","unstructured":"Kremer JM, Bigauoette J, Michalek AV, Timchalk MA, Lininger L, Rynes RI, et al. Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet. 1985;1(8422):184\u20137.","journal-title":"Lancet"},{"issue":"1","key":"2781_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/03009742.2017.1287304","volume":"47","author":"S Kristensen","year":"2018","unstructured":"Kristensen S, Schmidt EB, Schlemmer A, Rasmussen C, Johansen MB, Christensen JH. Beneficial effect of n-3 polyunsaturated fatty acids on inflammation and analgesic use in psoriatic arthritis: a randomized, double blind, placebo-controlled trial. Scand J Rheumatol. 2018;47(1):27\u201336.","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"2781_CR36","doi-asserted-by":"publisher","first-page":"867","DOI":"10.7326\/0003-4819-119-9-199311010-00001","volume":"119","author":"LJ Leventhal","year":"1993","unstructured":"Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann Intern Med. 1993;119(9):867\u201373.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2781_CR37","first-page":"307","volume":"33","author":"TM Madland","year":"2006","unstructured":"Madland TM, Bj\u00f6rkkjaer T, Brunborg LA, Fr\u00f6yland L, Berstad A, Brun JG. Subjective improvement in patients with psoriatic arthritis after short-term oral treatment with seal oil. A pilot study with double blind comparison to soy oil. J Rheumatol. 2006;33(2):307\u201310.","journal-title":"J Rheumatol"},{"issue":"7","key":"2781_CR38","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1136\/ard.51.7.877","volume":"51","author":"M Magar\u00f2","year":"1992","unstructured":"Magar\u00f2 M, Zoli A, Altomonte L, Mirone L, De Sole P, Di Mario G, et al. Effect of fish oil on neutrophil chemiluminescence induced by different stimuli in patients with rheumatoid arthritis. Ann Rheum Dis. 1992;51(7):877\u201380.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2781_CR39","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1365-2362.1992.tb01431.x","volume":"22","author":"GL Nielsen","year":"1992","unstructured":"Nielsen GL, Faarvang KL, Thomsen BS, Teglbj\u00e6rg KL, Jensen LT, Hansen TM, et al. The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. Eur J Clin Invest. 1992;22(10):687\u201391.","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"2781_CR40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF00262088","volume":"14","author":"DC Nordstr\u00f6m","year":"1995","unstructured":"Nordstr\u00f6m DC, Honkanen VE, Nasu Y, Antila E, Friman C, Konttinen YT. Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed. Rheumatol Int. 1995;14(6):231\u20134.","journal-title":"Rheumatol Int"},{"issue":"7","key":"2781_CR41","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jnutbio.2012.11.004","volume":"24","author":"Y Park","year":"2013","unstructured":"Park Y, Lee A, Shim S-C, Lee JH, Choe J-Y, Ahn H, et al. Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea. J Nutr Biochem. 2013;24(7):1367\u201372.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"2781_CR42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3109\/03009749209099218","volume":"21","author":"L Sk\u00f6ldstam","year":"1992","unstructured":"Sk\u00f6ldstam L, B\u00f6rjesson O, Kj\u00e4llman A, Seiving B, \u00c5kesson B. Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double-blind, controlled study. Scand J Rheumatol. 1992;21(4):178\u201385.","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"2781_CR43","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/147323000403200501","volume":"32","author":"T Sundrarjun","year":"2004","unstructured":"Sundrarjun T, Komindr S, Archararit N, Dahlan W, Puchaiwatananon O, Angthararak S, et al. Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-\u03b1 and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis. J Int Med Res. 2004;32(5):443\u201354.","journal-title":"J Int Med Res"},{"issue":"5","key":"2781_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/03009740600844357","volume":"35","author":"B Sundstr\u00f6m","year":"2006","unstructured":"Sundstr\u00f6m B, St\u00e5lnacke K, Hagfors L, Johansson G. Supplementation of omega-3 fatty acids in patients with ankylosing spondylitis. Scand J Rheumatol. 2006;35(5):359\u201362.","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"2781_CR45","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/art.1780330914","volume":"33","author":"JE Tulleken","year":"1990","unstructured":"Tulleken JE, Limburg PC, Muskiet FAJ, Rijswijk MHV. Vitamin e status during dietary fish oil supplementation in rheumatoid arthritis. Arthritis Rheum. 1990;33(9):1416\u20139.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2781_CR46","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/rheumatology\/33.10.954","volume":"33","author":"DJ Veale","year":"1994","unstructured":"Veale DJ, Torley HI, Richards IM, O\u2019Dowd A, Fitzsimons C, Belch JJ, et al. A double-blind placebo controlled trial of Efamol Marine on skin and joint symptoms of psoriatic arthritis. Br J Rheumatol. 1994;33(10):954\u20138.","journal-title":"Br J Rheumatol"},{"key":"2781_CR47","doi-asserted-by":"crossref","unstructured":"Veselinovic M, Vasiljevic D, Vucic V, Arsic A, Petrovic S, Tomic-Lucic A, et al. Clinical benefits of n-3 PUFA and \u0264-linolenic acid in patients with rheumatoid arthritis. Nutrients. 2017;9(4):325.","DOI":"10.3390\/nu9040325"},{"issue":"10","key":"2781_CR48","first-page":"2343","volume":"27","author":"D Volker","year":"2000","unstructured":"Volker D, Fitzgerald P, Major G, Garg M. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol. 2000;27(10):2343\u20136.","journal-title":"J Rheumatol"},{"issue":"11","key":"2781_CR49","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1002\/art.1780391106","volume":"39","author":"RB Zurier","year":"1996","unstructured":"Zurier RB, Rossetti RG, Jacobson EW, DeMarco DM, Liu NY, Temming JE, et al. gamma-Linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. Arthritis Rheum. 1996;39(11):1808\u201317.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2781_CR50","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00296-015-3415-x","volume":"36","author":"PC Taylor","year":"2016","unstructured":"Taylor PC, Moore A, Vasilescu R, Alvir J, Tarallo M. A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective. Rheumatol Int. 2016;36(5):685\u201395.","journal-title":"Rheumatol Int"},{"issue":"4","key":"2781_CR51","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1756-185X.2012.01752.x","volume":"15","author":"H Wen","year":"2012","unstructured":"Wen H, Ralph Schumacher H, Li X, Gu J, Ma L, Wei H, et al. Comparison of expectations of physicians and patients with rheumatoid arthritis for rheumatology clinic visits: a pilot, multicenter, international study. Int J Rheum Dis. 2012;15(4):380\u20139.","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"2781_CR52","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1136\/ard.2008.100271","volume":"68","author":"L Gossec","year":"2009","unstructured":"Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, et al. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis. 2009;68(11):1680\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2781_CR53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.expneurol.2004.09.003","volume":"191","author":"J Clarke","year":"2005","unstructured":"Clarke J, Herzberg G, Peeling J, Buist R, Corbett D. Dietary supplementation of omega-3 polyunsaturated fatty acids worsens forelimb motor function after intracerebral hemorrhage in rats. Exp Neurol. 2005;191(1):119\u201327.","journal-title":"Exp Neurol"},{"issue":"1","key":"2781_CR54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","volume":"380","author":"DL Bhatt","year":"2019","unstructured":"Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380(1):11\u201322.","journal-title":"N Engl J Med"},{"issue":"2","key":"2781_CR55","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/heartjnl-2020-316780","volume":"107","author":"EC Rizos","year":"2021","unstructured":"Rizos EC, Markozannes G, Tsapas A, Mantzoros CS, Ntzani EE. Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis. Heart. 2021;107(2):150\u20138.","journal-title":"Heart."},{"issue":"22","key":"2781_CR56","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1001\/jama.2020.22258","volume":"324","author":"SJ Nicholls","year":"2020","unstructured":"Nicholls SJ, Lincoff AM, Garcia M, Bash D, Ballantyne CM, Barter PJ, et al. Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial. JAMA. 2020;324(22):2268\u201380.","journal-title":"JAMA"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02781-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02781-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02781-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T10:16:11Z","timestamp":1651918571000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02781-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2781"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02781-2","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.JSi: consulting fees: Sandoz, Novartis; SM: none; YN: none; PS: none; JGL: consulting fees: S\u00eameia; MS: none; SC: consulting fees: Lilly, Janssen, BMS, Fresenius Kabi, Novonordisk, Servier, Bariatek, Fitforme, Mygoodlife; RMF: none; Jse: consulting fees: Roche, Chugai, Pfizer, BMS, MSD, Biogen, Abbvie, Sandoz, Janssen, Novartis, Fresenius Kabi, Sanofi, research grants: Pfizer, MSD, Schwa Medico; CD: consulting fees: Abbvie, Abivax, BMS, Fresenius Kabi, Novartis, Pfizer, Sandoz, Sanofi, Roche- Chugai, UCB.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}